Department of Neurology, Hospital Clínico San Carlos, San Carlos Health Research Institute (IdISSC), Universidad Complutense de Madrid, Madrid, Spain.
Department of Nuclear Medicine, Hospital Clínico San Carlos, San Carlos Health Research Institute (IdISSC), Universidad Complutense de Madrid, Madrid, Spain.
J Alzheimers Dis. 2018;61(1):103-111. doi: 10.3233/JAD-170604.
The Free and Cued Selective Reminding Test (FCSRT) is the most accurate test for the diagnosis of prodromal Alzheimer's disease (AD). Recently, a novel cognitive test, the Loewenstein-Acevedo Scale for Semantic Interference and Learning (LASSI-L), has been developed in order to provide an early diagnosis.
To compare the diagnostic accuracy of the FCSRT and the LASSI-L for the diagnosis of AD in its preclinical and prodromal stages using 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) as a reference.
Fifty patients consulting for subjective memory complaints without functional impairment and at risk for AD were enrolled and evaluated using FCSRT, LASSI-L, and FDG-PET. Participants were evaluated using a comprehensive neurological and neuropsychological protocol and were assessed with the FCSRT and LASSI-L. FDG-PET was acquired concomitantly and used for classification of patients as AD or non-AD according to brain metabolism using both visual and semi-quantitative methods.
LASSI-L scores allowed a better classification of patients as AD/non-AD in comparison to FCSRT. Logistic regression analysis showed delayed recall and failure to recovery from proactive semantic interference from LASSI-L as independent statistically significant predictors, obtaining an area under the curve of 0.894. This area under the curve provided a better discrimination than the best FCSRT score (total delayed recall, area under the curve 0.708, p = 0.029).
The LASSI-L, a cognitive stress test, was superior to FCSRT in the prediction of AD features on FDG-PET. This emphasizes the possibility to advance toward an earlier diagnosis of AD from a clinical perspective.
自由和线索选择性回忆测试(FCSRT)是诊断前驱期阿尔茨海默病(AD)最准确的测试。最近,开发了一种新的认知测试,Loewenstein-Acevedo 语义干扰和学习量表(LASSI-L),以提供早期诊断。
使用 18F-氟脱氧葡萄糖正电子发射断层扫描(FDG-PET)作为参考,比较 FCSRT 和 LASSI-L 对 AD 临床前和前驱期的诊断准确性。
招募了 50 名因主观记忆问题就诊但无功能障碍且有 AD 风险的患者,并使用 FCSRT、LASSI-L 和 FDG-PET 进行评估。参与者接受了全面的神经学和神经心理学评估,并使用 FCSRT 和 LASSI-L 进行评估。同时进行 FDG-PET 采集,并使用视觉和半定量方法根据大脑代谢将患者分类为 AD 或非 AD。
与 FCSRT 相比,LASSI-L 评分可以更好地对患者进行 AD/非 AD 的分类。逻辑回归分析显示,延迟回忆和无法从 LASSI-L 的主动语义干扰中恢复是独立的统计学显著预测因子,获得 0.894 的曲线下面积。该曲线下面积提供了比最佳 FCSRT 评分(总延迟回忆,曲线下面积 0.708,p=0.029)更好的区分度。
LASSI-L 是一种认知应激测试,在预测 FDG-PET 上的 AD 特征方面优于 FCSRT。这强调了从临床角度提前诊断 AD 的可能性。